Catalent

News

Catalent celebrates the 30th anniversary of its production facility in Limoges
Date: 12/18/2007

SOMERSET, NJ – DECEMBER 18, 2007 – Catalent Pharma Solutions, one of the leading providers of advanced dose form and packaging technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies, is celebrating 30 years of production at its facility in Limoges, France.

The Limoges production site covers 10,000 m² and employs over 144 qualified people. It produces over 40 million units a year and today, the facility primarily manufactures:

  • Pouches of solutions for the conservation of organs and the intravenous feeding of children and premature babies and contrast products for radiography.
  • Syringes ready-filled with low molecular weight heparins.
  • Syringes of gel for filling wrinkles.


In addition to these activities, the Limoges site also undertakes the secondary packaging of syringes of anti-flu vaccines. The strength of its specialist knowledge and skill in sterilization and aseptic procedures has meant that the Limoges facility has become a reliable asset in the sphere of pharmaceutical technologies.

Jean Tronchet, director of Catalent’s site in Limoges, is proud to celebrate this anniversary which marks a shared achievement. “We are happy that we have a strong and lasting image in the world thanks to our unique skill. We are continuing to capitalise on our strengths: our customer service, skill, independence and installations, which make this site a modern and productive tool in the service of our customers”, Tronchet explains.

About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. The company applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 10,000 at more than 30 facilities worldwide and generates more than $1.7 billion in annual revenue. For more information, visit www.catalent.com.